CARL KINZEL: Open Payments
NPI 1992983209 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 87 payments from 22 companies in 2025. Trend: 2023 $2,208 · 2024 $2,362 · 2025 $1,882
Food & beverage: $1,882
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $213 |
| AstraZeneca Pharmaceuticals LP | 8 | $204 |
| Janssen Pharmaceuticals, Inc | 3 | $182 |
| Axsome Therapeutics, Inc. | 9 | $166 |
| Insulet Corporation | 5 | $165 |
| PFIZER INC. | 8 | $155 |
| Otsuka America Pharmaceutical, Inc. | 4 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| Astellas Pharma US Inc | 3 | $67 |
Products named: SPRAVATO, Auvelity, Omnipod, Wegovy, AIRSUPRA, REXULTI, NURTEC ODT, CAPLYTA.
Industry payments across MI — which companies pay providers there.
